M Vest Water Valuation

Is 7YA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 7YA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 7YA (€0.85) is trading below our estimate of fair value (€5.56)

Significantly Below Fair Value: 7YA is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 7YA?

Key metric: As 7YA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 7YA. This is calculated by dividing 7YA's market cap by their current revenue.
What is 7YA's PS Ratio?
PS Ratio15.7x
SalesNOK 19.14m
Market CapNOK 301.00m

Price to Sales Ratio vs Peers

How does 7YA's PS Ratio compare to its peers?

The above table shows the PS ratio for 7YA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.7x
BNN BRAIN Biotech
1.2x8.5%€70.6m
BIG1 Bio-Gate
0.8x16.3%€6.5m
2HRA H&R GmbH KGaA
0.1x2.7%€127.3m
NTG Nabaltec
0.6x4.7%€122.8m
7YA M Vest Water
15.7x36.4%€301.0m

Price-To-Sales vs Peers: 7YA is expensive based on its Price-To-Sales Ratio (15.7x) compared to the peer average (0.7x).


Price to Sales Ratio vs Industry

How does 7YA's PS Ratio compare vs other companies in the DE Chemicals Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
2HRA H&R GmbH KGaA
0.1x2.7%US$133.44m
NSAK OTI Greentech
0.03xn/aUS$602.27k
B7Y Byotrol
0.04xn/aUS$246.97k
No more companies available in this PS range
7YA 15.7xIndustry Avg. 1.0xNo. of Companies5PS00.40.81.21.62+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 7YA is expensive based on its Price-To-Sales Ratio (15.7x) compared to the European Chemicals industry average (1x).


Price to Sales Ratio vs Fair Ratio

What is 7YA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

7YA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio15.7x
Fair PS Ratio1x

Price-To-Sales vs Fair Ratio: 7YA is expensive based on its Price-To-Sales Ratio (15.7x) compared to the estimated Fair Price-To-Sales Ratio (1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 7YA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€0.85
€1.04
+22.8%
6.6%€1.11€0.98n/a2
Nov ’25€0.83
€1.04
+24.1%
6.6%€1.10€0.97n/a2
Oct ’25€0.81
€1.04
+27.9%
6.6%€1.10€0.97n/a2
Apr ’25€0.71
€1.07
+50.0%
6.6%€1.14€1.00n/a2
Mar ’25€0.79
€0.98
+24.0%
1.8%€1.00€0.96n/a2
Feb ’25€0.68
€0.83
+21.5%
20.6%€1.00€0.66n/a2
Jan ’25n/a
€0.83
0%
23.1%€1.02€0.64n/a2

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies